http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1029865-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
filingDate 1999-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62126a41cca7097310b646cf3f544c81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9393652a30d3fd83bd4a138e85a6993
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12d3610f69f32de6f80a3b8e2b8c57f4
publicationDate 2000-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1029865-A3
titleOfInvention Process and intermediates for preparing 5-lipoxygenase inhibitors
abstract The present invention relates to the process for preparing a compound of the formulan n   wherein A is C 1 -C 6 alkyl, an aryl which is mono or disubstituted with F, Cl , Br,, OCH 3 ,nC 1 -C 3 alkyl or benzy. In the preferred compound A is CH 3 . The 5-lipoxygenase inhibitors thatnare prepared in accordance with the present invention are selective inhibitors of the action ofnlipoxygenase enzyme and are useful in the treatment or alleviation of inflammatory diseases,nallergy and cardiovascular diseases in mammals.
priorityDate 1998-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5883106-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9429299-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9611911-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0488602-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128611908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128069515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129424602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129929078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127476038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID428951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127540816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129037712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129518053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129560389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11459787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14510

Total number of triples: 53.